FDA Approves Omeros’ YARTEMLEA® – First and Only Therapy Indicated for TA-TMA
Approval of YARTEMLEA was based on results from a single-arm, open-label study in adults with TA-TMA (the TA-TMA…
CRISPR Screen Identifies GATOR1 as Lymphoma Tumor Suppressor
Credit: CoRus13 via Wikimedia Commons A team of Australian researchers has identified a set of genes that encode…